All In MedTech

Device Trial Radar · NCT00784043

Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant

Longitudinal Efficacy in Young Children Implanted Bilaterally With MED-EL COMBI 40+ / PULSARCI100/SONATATI100 Cochlear Implant Systems.

Last checked: Nov 20, 2026Latest source record: May 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

37

Actual

Start

Mar 2004

Primary completion

Sep 2009

Study completion Feb 2017

Sponsor

Lead sponsor
Med-El CorporationNot on our public-company list
Sponsor type
Industry
First posted
Nov 3, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 12 months, up to 36 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate and document longitudinal efficacy in young children implanted bilaterally with MED-EL COMBI 40+ / PULSARCI100/SONATATI100 cochlear implant systems.

Conditions

  • Hearing Loss

Interventions

  • Cochlear ImplantDevice

    Bilateral Implantation in children

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Longitudinal Efficacy in Young Children Implanted Bilaterally With MED-EL COMBI 40+ / PULSARCI100/SONATATI100 Cochlear Implant SystemsTime frame: 60 months post initial stimulation

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • Nemours Children's Clinic

    Jacksonville, Florida

  • Children's Healthcare of Atlanta

    Atlanta, Georgia

  • Cleveland Clinic Foundation

    Cleveland, Ohio

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.